Here is the latest stock price and chart of SYNCOM FORMULATIONS. For more details, see the SYNCOM FORMULATIONS company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
For a Limited Time: Get 3 Years of Access at the Price of 1
Live BSE Quotes | May 10, 2024 (Close) | ||
---|---|---|---|
Price (Rs)13.05 | Open (Rs) 12.95 | High (Rs) 13.22 | Low (Rs) 12.80 |
% Change0.54 | Volume 621,303 | Value (Rs) 8,078,022 | 52-Week H/L 18.65 / 6.07 |
Live NSE Quotes |
---|
Not listed |
Change | |||||
---|---|---|---|---|---|
1 Day 0.54% | 1 Month -1.51% | 3 Months -15.48% | 1 Year 113.93% | 5 Years (CAGR)* 67.49% | 10 Years (CAGR)* 13.13% |
* Compound Annual Growth Rate
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* 0.28 | P/E Ratio (x) 46.49 | Market Cap (Rs m) 12,267.00 | P/BV (x) 4.43 | Dividend Yield (%) 0.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX
|
||||||
PERIOD |
SYNCOM FORMULATIONS last traded price was up 0.5% to Rs 13.1 on the BSE. The total volume of shares traded was 0.6 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.9%. And the benchmark S&P BSE SENSEX was at 72,664.5 (up 0.4%).
Over the last 30 days, the SYNCOM FORMULATIONS share price is down 1.7%. And over the last one year, SYNCOM FORMULATIONS share price is up 113.2%.
The current market capitalisation of SYNCOM FORMULATIONS stands at Rs 12,267.00 m. For more information, check out the list of top 100 companies in India in terms of market cap.
As of March 2024, company promoters held 50.57% stake in SYNCOM FORMULATIONS, with no shares having been pledged. To know more, check out the latest shareholding pattern of SYNCOM FORMULATIONS.
Before you go, here's an alert on SYNCOM FORMULATIONS you may want to take note of...
Date | Announcement | Ex-Date |
---|---|---|
17-May-2024 | Quarterly Results | - |
List of All Upcoming Corporate Actions
The last traded price of SYNCOM FORMULATIONS was Rs 13.1 on the BSE, up 0.5% over the previous close.
The current market capitalisation of SYNCOM FORMULATIONS stands at Rs 12,267 m.
SYNCOM FORMULATIONS had an EPS of Rs 0.3 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 0.1.
For the financial year 2023, SYNCOM FORMULATIONS declared dividend amounting to Rs 0.0 per share. At the current price of Rs 13.1, this results in a dividend yield of 0.0%.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.